Clinical Trials Directory

Trials / Completed

CompletedNCT02195609

Evaluate the Effect of Omega-3 vs Soy Isoflavones in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms

Randomized Open Label Study to Evaluate the Effect of (Omega-3) EPA + Docosahexaenoic Acid (DHA) vs Soy Isoflavones in 100 Postmenopausal Women Between 45-65 Years With Moderate to Severe Vasomotor Symptoms.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
75 (actual)
Sponsor
Instituto Palacios · Academic / Other
Sex
Female
Age
45 Years – 65 Years
Healthy volunteers
Accepted

Summary

This study is aiming to evaluate changes in vasomotor symptoms in postmenopausal women treated for 4 months with Omega-3 vs Soy Isoflavones.

Detailed description

This is a non-inferiority study of Omega 3 versus Soy Isoflavones, being each patient its own control from the baseline. In order to determine the difference observed in the evolution of intensity, frequency and the total number of hot flashes in 4 months in patients treated with Omega-3 vs Soy Isoflavones, is planned to include at least 100 patients, 50 per treatment arm. It si estimated a standar deviation of 0.5%, and a 10% lost follow-up rate.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTOmega-3600 mg oral twice a day
DIETARY_SUPPLEMENTSoy Isoflavones54.4 mg oral twice a day

Timeline

Start date
2014-03-01
Primary completion
2015-09-01
Completion
2015-11-01
First posted
2014-07-21
Last updated
2016-09-16

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT02195609. Inclusion in this directory is not an endorsement.